Strategic Partnerships Fulgent Genetics has been actively engaging in partnerships with other companies in the biotechnology and healthcare industry, such as the recent collaboration with Mission Bio Inc. This indicates potential sales opportunities through offering genomic testing services to partners' clients or leveraging each other's technology for mutual benefit.

Product Diversification With a wide range of products and services in oncology, bioinformatics, and reproductive health, Fulgent Genetics can explore cross-selling opportunities to existing clients. By bundling different testing services or introducing new products to the market, Fulgent can expand its revenue streams and capture untapped market segments.

Investment Incentives Recent investments from Aigen Investment Management LP and Brandywine Global Investment Management, LLC. highlight investor confidence in Fulgent Genetics' growth potential. This financial backing can be leveraged to fuel sales initiatives, expand marketing efforts, or develop innovative technologies to attract new customers and retain existing ones.

Executive Leadership Influence The addition of Reggie Groves to the board of directors brings in fresh perspectives and expertise, potentially opening new doors for strategic partnerships or business development opportunities. Groves' network and industry knowledge could be utilized to access new markets or enhance Fulgent's positioning in the competitive landscape.

Competitive Positioning & Market Analysis By comparing Fulgent Genetics with similar companies like Genomic Health, Myriad Genetics, and Illumina, sales teams can identify gaps in the market or potential customer segments that are underserved. Analyzing competitors' strategies and market positioning can help Fulgent refine its sales approach and differentiate its offerings to appeal to a broader customer base.